Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Alexion Pharmaceuticals reports increased revenues of 11% in third quarter 2009

Alexion Pharmaceuticals reports increased revenues of 11% in third quarter 2009

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

ImmunoCellular Therapeutics files a provisional patent application

ImmunoCellular Therapeutics files a provisional patent application

Interim results from Phase 1 CAL-101 trial for chronic lymphocytic leukemia

Interim results from Phase 1 CAL-101 trial for chronic lymphocytic leukemia

Preclinical data of carfilzomib and PR-957 inhibitors to be presented at 2009 ACR/ARHP meeting

Preclinical data of carfilzomib and PR-957 inhibitors to be presented at 2009 ACR/ARHP meeting

Managing Myeloma launches educational activities for multidisciplinary professionals

Managing Myeloma launches educational activities for multidisciplinary professionals

Managing Myeloma website offers scholarship for attending the December 2009 American Society of Hematology Annual Meeting

Managing Myeloma website offers scholarship for attending the December 2009 American Society of Hematology Annual Meeting

Veterans Affairs establishes service-connection benefits for Vietnam Veterans

Veterans Affairs establishes service-connection benefits for Vietnam Veterans

Johnson & Johnson announces financial results for the third quarter of 2009

Johnson & Johnson announces financial results for the third quarter of 2009

Compugen, Bayer Schering Pharma sign collaboration agreement for tumor research

Compugen, Bayer Schering Pharma sign collaboration agreement for tumor research

Onyx Pharmaceuticals signs definitive agreement to acquire Proteolix

Onyx Pharmaceuticals signs definitive agreement to acquire Proteolix

Keryx Biopharmaceuticals commences Phase 2 clinical study evaluating KRX-0401 for Chronic Lymphocytic Leukemia

Keryx Biopharmaceuticals commences Phase 2 clinical study evaluating KRX-0401 for Chronic Lymphocytic Leukemia

pDCs promote growth and survival of malignant myeloma cells

pDCs promote growth and survival of malignant myeloma cells

BioImagene announces launch of the Virtuoso digital pathology solution

BioImagene announces launch of the Virtuoso digital pathology solution

Seattle Genetics discontinues its SeaGen MARINER clinical trial for large B-cell lymphoma

Seattle Genetics discontinues its SeaGen MARINER clinical trial for large B-cell lymphoma

Quest PharmaTech acquires immunotherapeutic antibody products from Paladin Labs

Quest PharmaTech acquires immunotherapeutic antibody products from Paladin Labs

Leading oncology experts to discuss management of hematological malignancies

Leading oncology experts to discuss management of hematological malignancies

Amgen announces results of Phase 3 head-to-head trial evaluating denosumab versus Zometa

Amgen announces results of Phase 3 head-to-head trial evaluating denosumab versus Zometa

Investigative drug hampers the survival of non-Hodgkin lymphoma cells

Investigative drug hampers the survival of non-Hodgkin lymphoma cells

Amgen announces results of Phase 3 trial in the treatment of bone metastases

Amgen announces results of Phase 3 trial in the treatment of bone metastases